Cargando…

MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin

BACKGROUND: The use of doxorubicin is associated with an increased risk of acute and long-term cardiomyopathy. Despite the constantly growing number of cancer survivors, little is known about the transcriptional mechanisms which progress in the time leading to a severe cardiac outcome. It is also un...

Descripción completa

Detalles Bibliográficos
Autores principales: Totoń-Żurańska, Justyna, Sulicka-Grodzicka, Joanna, Seweryn, Michał T., Pitera, Ewelina, Kapusta, Przemysław, Konieczny, Paweł, Drabik, Leszek, Kołton-Wróż, Maria, Chyrchel, Bernadeta, Nowak, Ewelina, Surdacki, Andrzej, Grodzicki, Tomasz, Wołkow, Paweł P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753431/
https://www.ncbi.nlm.nih.gov/pubmed/36517751
http://dx.doi.org/10.1186/s10020-022-00588-0
_version_ 1784850961501519872
author Totoń-Żurańska, Justyna
Sulicka-Grodzicka, Joanna
Seweryn, Michał T.
Pitera, Ewelina
Kapusta, Przemysław
Konieczny, Paweł
Drabik, Leszek
Kołton-Wróż, Maria
Chyrchel, Bernadeta
Nowak, Ewelina
Surdacki, Andrzej
Grodzicki, Tomasz
Wołkow, Paweł P.
author_facet Totoń-Żurańska, Justyna
Sulicka-Grodzicka, Joanna
Seweryn, Michał T.
Pitera, Ewelina
Kapusta, Przemysław
Konieczny, Paweł
Drabik, Leszek
Kołton-Wróż, Maria
Chyrchel, Bernadeta
Nowak, Ewelina
Surdacki, Andrzej
Grodzicki, Tomasz
Wołkow, Paweł P.
author_sort Totoń-Żurańska, Justyna
collection PubMed
description BACKGROUND: The use of doxorubicin is associated with an increased risk of acute and long-term cardiomyopathy. Despite the constantly growing number of cancer survivors, little is known about the transcriptional mechanisms which progress in the time leading to a severe cardiac outcome. It is also unclear whether long-term transcriptomic alterations related to doxorubicin use are similar to transcriptomic patterns present in patients suffering from other cardiomyopathies. METHODS: We have sequenced miRNA from total plasma and extracellular vesicles (EVs) from 66 acute lymphoblastic leukemia (ALL) survivors and 61 healthy controls (254 samples in total). We then analyzed processes regulated by differentially expressed circulating miRNAs and cross-validated results with the data of patients with clinically manifested cardiomyopathies. RESULTS: We found that especially miRNAs contained within EVs may be informative in terms of cardiomyopathy development and may regulate pathways related to neurotrophin signaling, transforming growth factor beta (TGFβ) or epidermal growth factor receptors (ErbB). We identified vesicular miR-144-3p and miR-423-3p as the most variable between groups and significantly correlated with echocardiographic parameters and, respectively, for plasma: let-7g-5p and miR-16-2-3p. Moreover, vesicular miR-144-3p correlates with the highest number of echocardiographic parameters and is differentially expressed in the circulation of patients with dilated cardiomyopathy. We also found that distribution of particular miRNAs between of plasma and EVs (proportion between compartments) e.g., miR-184 in ALL, is altered, suggesting changes within secretory and miRNA sorting mechanisms. CONCLUSIONS: Our results show that transcriptomic changes resulting from doxorubicin induced myocardial injury are reflected in circulating miRNA levels and precede development of the late onset cardiomyopathy phenotype. Among miRNAs related to cardiac function, we found vesicular miR-144-3p and miR-423-3p, as well as let-7g-5p and miR-16-2-3p contained in the total plasma. Selection of source for such studies (plasma or EVs) is of critical importance, as distribution of some miRNA between plasma and EVs is altered in ALL survivors, in comparison to healthy people, which suggests that doxorubicin-induced changes include miRNA sorting and export to extracellular space. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-022-00588-0.
format Online
Article
Text
id pubmed-9753431
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97534312022-12-16 MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin Totoń-Żurańska, Justyna Sulicka-Grodzicka, Joanna Seweryn, Michał T. Pitera, Ewelina Kapusta, Przemysław Konieczny, Paweł Drabik, Leszek Kołton-Wróż, Maria Chyrchel, Bernadeta Nowak, Ewelina Surdacki, Andrzej Grodzicki, Tomasz Wołkow, Paweł P. Mol Med Research Article BACKGROUND: The use of doxorubicin is associated with an increased risk of acute and long-term cardiomyopathy. Despite the constantly growing number of cancer survivors, little is known about the transcriptional mechanisms which progress in the time leading to a severe cardiac outcome. It is also unclear whether long-term transcriptomic alterations related to doxorubicin use are similar to transcriptomic patterns present in patients suffering from other cardiomyopathies. METHODS: We have sequenced miRNA from total plasma and extracellular vesicles (EVs) from 66 acute lymphoblastic leukemia (ALL) survivors and 61 healthy controls (254 samples in total). We then analyzed processes regulated by differentially expressed circulating miRNAs and cross-validated results with the data of patients with clinically manifested cardiomyopathies. RESULTS: We found that especially miRNAs contained within EVs may be informative in terms of cardiomyopathy development and may regulate pathways related to neurotrophin signaling, transforming growth factor beta (TGFβ) or epidermal growth factor receptors (ErbB). We identified vesicular miR-144-3p and miR-423-3p as the most variable between groups and significantly correlated with echocardiographic parameters and, respectively, for plasma: let-7g-5p and miR-16-2-3p. Moreover, vesicular miR-144-3p correlates with the highest number of echocardiographic parameters and is differentially expressed in the circulation of patients with dilated cardiomyopathy. We also found that distribution of particular miRNAs between of plasma and EVs (proportion between compartments) e.g., miR-184 in ALL, is altered, suggesting changes within secretory and miRNA sorting mechanisms. CONCLUSIONS: Our results show that transcriptomic changes resulting from doxorubicin induced myocardial injury are reflected in circulating miRNA levels and precede development of the late onset cardiomyopathy phenotype. Among miRNAs related to cardiac function, we found vesicular miR-144-3p and miR-423-3p, as well as let-7g-5p and miR-16-2-3p contained in the total plasma. Selection of source for such studies (plasma or EVs) is of critical importance, as distribution of some miRNA between plasma and EVs is altered in ALL survivors, in comparison to healthy people, which suggests that doxorubicin-induced changes include miRNA sorting and export to extracellular space. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-022-00588-0. BioMed Central 2022-12-14 /pmc/articles/PMC9753431/ /pubmed/36517751 http://dx.doi.org/10.1186/s10020-022-00588-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Totoń-Żurańska, Justyna
Sulicka-Grodzicka, Joanna
Seweryn, Michał T.
Pitera, Ewelina
Kapusta, Przemysław
Konieczny, Paweł
Drabik, Leszek
Kołton-Wróż, Maria
Chyrchel, Bernadeta
Nowak, Ewelina
Surdacki, Andrzej
Grodzicki, Tomasz
Wołkow, Paweł P.
MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
title MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
title_full MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
title_fullStr MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
title_full_unstemmed MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
title_short MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
title_sort microrna composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753431/
https://www.ncbi.nlm.nih.gov/pubmed/36517751
http://dx.doi.org/10.1186/s10020-022-00588-0
work_keys_str_mv AT totonzuranskajustyna micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT sulickagrodzickajoanna micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT sewerynmichałt micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT piteraewelina micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT kapustaprzemysław micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT koniecznypaweł micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT drabikleszek micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT kołtonwrozmaria micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT chyrchelbernadeta micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT nowakewelina micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT surdackiandrzej micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT grodzickitomasz micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin
AT wołkowpawełp micrornacompositionofplasmaextracellularvesiclesaharbingeroflatecardiotoxicityofdoxorubicin